Results 181 to 190 of about 677,451 (361)

Treatment of peri‐implantitis with diode laser or mucosal flap surgery: A clinical randomized controlled trial

Journal of Periodontology, EarlyView.
Abstract Background Peri‐implantitis poses a major challenge as contemporary nonsurgical treatments show dissatisfactory results and mucosal flap surgery is often needed. Diode lasers can remove granulation tissue and submucosal bacteria, and if it achieves similar clinical results, then it could be used as a less invasive first approach.
Sebastian Malmqvist, Talat Qadri, Ronaldo Lira‐Junior, Elisabeth A. Boström, Anders Gustafsson, Georgios N. Belibasakis, Angelika Silbereisen, Gunnar Johannsen, Annsofi Johannsen   +8 more
wiley   +1 more source

Obliteration of oral and maxillofacial region by SARS-CoV-2 infection. [PDF]

GMS Hyg Infect Control
Shunmugavelu K, Saravanan J.
europepmc   +1 more source

IN VITRO ADSORPTION OF DEXTRANASE BY DENTAL PLAQUE AND BUCCAL MUCOSA, AND ITS ORAL RETENTION AFTER RINSING THE MOUTH

, 1978
Katsuyuki Futakami, Tatsuo KIYOSHIGE, Yoji Yamazaki, Motoo Niwa   +3 more
openalex   +2 more sources

Randomized clinical trial evaluating kinetic benefits of desensitizing agents: Magnitude, onset, and stability of relief

Journal of Periodontology, EarlyView.
Abstract Background Dentin hypersensitivity (DH) is common, particularly among periodontal patients. This trial evaluated magnitude of desensitizing benefit, onset of action, and complete relief of three dentifrices with distinct desensitizing technologies.
Aaron R. Biesbrock, Tao He, Yuanshu Zou, Julie M. Grender, Pejmon Amini, Paul A. Sagel, Andrew Groth, Malgorzata Klukowska   +7 more
wiley   +1 more source

Midline (dermoid) cysts of the floor of the mouth: report of 16 cases and review of surgical techniques. [PDF]

, 2003
CALIFANO, LUIGI, DE MARIA G., LONGO F, MANGONE G. M, MAREMOTI P   +4 more
core   +1 more source

Clinical and histological indicators for malignant transformation of oral submucous fibrosis: an analysis of cases from a tertiary care center. [PDF]

BMC Oral Health
Naik V, Kumar M, Solomon MC, Chandrashekhar C, Guddattu V.   +4 more
europepmc   +1 more source

Comparative study of cell alterations in oral lichen planus and epidermoid carcinoma of the mouth mucosa

, 2009
Fernando Augusto Cervantes Garcia de Sousa, Thaís Cachuté Paradella, Adriana Aigotti Haberbeck Brandão, Luiz Eduardo Blumer Rosa   +3 more
openalex   +1 more source

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence‐based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite advances in the management of ambulatory paediatric ulcerative colitis (UC), challenges remain as many patients are refractory to therapy and some require colectomy. The aim of these guidelines is to provide an update on optimal care for UC through detailed recommendations and practice points. Methods These guidelines are an
Eytan Wine, Marina Aloi, Stephanie Van Biervliet, Jiri Bronsky, Javier Martín di Carpi, Marco Gasparetto, Laura Gianolio, Hannah Gordon, Iva Hojsak, Alexandra S. Hudson, Séamus Hussey, Johan van Limbergen, Erasmo Miele, Lorenzo Norsa, Ola Olén, Gianluca Pellino, Patrick van Rheenen, Lissy de Ridder, Richard K. Russell, Dror S. Shouval, Eunice Trindade, Dan Turner, David C. Wilson, Anat Yerushalmy Feler, Amit Assa   +24 more
wiley   +1 more source

Oral manifestations in patients with chronic hepatitis C. [PDF]

BMC Oral Health
Brzdęk M, Gałuszka-Garnuszek J, Dobrowolska K, Brzdęk K, Janczura J, Tronina O, Kal M, Stępień P, Zarębska-Michaluk D.   +8 more
europepmc   +1 more source

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Inflammatory bowel diseases (IBD) require effective therapies to prevent morbidity and maintain quality of life. The introduction of biologic agents, beginning with monoclonal antibodies targeting tumor necrosis factor (TNF) alpha, has launched a new era of advancements that have markedly improved short‐ and long‐term outcomes of Crohn's ...
Lina M. Felipez, Sabina Ali, Edwin F. de Zoeten, Anne M. Griffiths, Sandra C. Kim, Ashish S. Patel, Joel R. Rosh, Jeremy Adler   +7 more
wiley   +1 more source